Literature DB >> 18201478

A multicentre audit of single-use surgical instruments (SUSI) for tonsillectomy and adenoidectomy.

P O'Flynn1, S Silva, P Kothari, R Persaud.   

Abstract

INTRODUCTION: Prions are resistant to conventional sterilisation procedures and, therefore, could be transmitted iatrogenically through re-usable adenoid and tonsil surgical instruments. Using disposable instruments would avoid the risk of transmission. We present the results of a complete audit loop using BBraun single-use surgical instruments (SUSI). PATIENTS AND METHODS: This was a prospective multicentre audit. Surgeons were asked to fill in a standardised questionnaire recording details including postoperative complications, and evaluation of each piece of equipment compared with their own experience of conventional re-usable instruments. In the first cycle, constructive criticisms of the instruments were noted and the manufacturers modified the instruments accordingly. A second cycle of audit was subsequently undertaken.
RESULTS: A total of 86 patients were audited in the first cycle and 97 in the second cycle. Postoperative haemorrhage rate for both cycles was well within acceptable range. In the first audit cycle, surgeons generally found the Draffin rods, Boyle-Davis gag and bipolar diathermy forceps of poor quality and difficult to use. These were redesigned and, on repeat evaluation during the second audit cycle, were found to be just as good, if not better, than the re-usable instruments.
CONCLUSIONS: This study suggests that SUSI may be just as good as re-usable instruments. Furthermore, they may be more cost effective.

Entities:  

Mesh:

Year:  2007        PMID: 18201478      PMCID: PMC2121230          DOI: 10.1308/003588407X205350

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  10 in total

Review 1.  Prions and the ENT surgeon.

Authors:  A Frosh
Journal:  J Laryngol Otol       Date:  1999-12       Impact factor: 1.469

Review 2.  Variant Creutzfeldt-Jakob disease (vCJD) and gastrointestinal endoscopy.

Authors:  A T Axon; U Beilenhoff; M G Bramble; S Ghosh; A Kruse; G E McDonnell; C Neumann; J F Rey; K Spencer
Journal:  Endoscopy       Date:  2001-12       Impact factor: 10.093

3.  Reusable versus disposable instruments in tonsillectomy: a comparative study of outcomes.

Authors:  A Maheshwar; M De; S T Browning
Journal:  Int J Clin Pract       Date:  2003-09       Impact factor: 2.503

4.  Increased post-tonsillectomy secondary haemorrhage with disposable instruments: an audit cycle.

Authors:  S Maini; E Waine; K Evans
Journal:  Clin Otolaryngol Allied Sci       Date:  2002-06

5.  Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein.

Authors:  Adam Frosh; Lorraine C Smith; Carl J Jackson; Jacqueline M Linehan; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  Lancet       Date:  2004 Oct 2-8       Impact factor: 79.321

Review 6.  Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease.

Authors:  David A Hilton
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

7.  Tonsillectomy technique as a risk factor for postoperative haemorrhage.

Authors:  D Lowe; J van der Meulen
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

8.  Effect of disposable instruments on paediatric post-tonsillectomy haemorrhage rates.

Authors:  Mary-Louise Montague; Michael S W Lee; S S Musheer Hussain
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2003-12       Impact factor: 1.675

9.  A new variant of Creutzfeldt-Jakob disease in the UK.

Authors:  R G Will; J W Ironside; M Zeidler; S N Cousens; K Estibeiro; A Alperovitch; S Poser; M Pocchiari; A Hofman; P G Smith
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

10.  Prions and disposable surgical instruments.

Authors:  P Nix
Journal:  Int J Clin Pract       Date:  2003-10       Impact factor: 2.503

  10 in total
  1 in total

1.  Recent medical devices for tonsillectomy.

Authors:  I Sayin; C Cingi
Journal:  Hippokratia       Date:  2012-01       Impact factor: 0.471

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.